Follow Project: “Surveillance of Metastatic Breast Cancer Patients on Oral Therapy”

Abstract

This article summarizes the construction of a project for the practical implementation of oral therapy in patients with advanced breast cancer undergoing oral treatment with one of the following options: Lapatinib, Everolimus, Pablociclib or Ribociclib. It went through two distinct stages: A phase I, a working group of experts was created a necessary and scientifically validated documentation on these therapeutics, toxicity management and interventions, following good clinical practice. A phase II, was created a informatic platform as a decision support tool in the different phases of management of these therapeutics, applied to a sample of 34 patients. It was a observational, longitudinal and prospective study.